Lilly Is Reinvesting In Diabetes, Injecting New Life Into Humalog Franchise
Executive Summary
Lilly is striving to reenergize its Humalog franchise in 2006 through a pending line extension and an expansion of its insulin production capacity, as the company seeks to rebuild its traditional strength in the diabetes category